Restructuring and innovation in pharmaceuticals and biotechs: the impact of financialisation

Gleadle, P., Parris, S., Shipman, A. and Simonetti, R. 2012. Restructuring and innovation in pharmaceuticals and biotechs: the impact of financialisation. Critical Perspectives on Accounting. 25 (1), pp. 67-77. doi:10.1016/j.cpa.2012.10.003

TitleRestructuring and innovation in pharmaceuticals and biotechs: the impact of financialisation
AuthorsGleadle, P., Parris, S., Shipman, A. and Simonetti, R.
Abstract

In this paper we explore whether a financialisation perspective can provide a more empirically satisfying account of recent developments in the pharmaceutical industry than the more commonly used resource-based or transaction cost approaches. Specifically, we note the evolution of the pharmaceutical industry structure from giant vertically integrated firms, selling patent protected blockbuster products at premium prices, to greater vertical disintegration. Big Pharma1 now sources a significant volume of early stage R&D activity externally, through outright acquisitions or alliances, especially with biotechnology firms. Much of the reason for such vertical disintegration is to be found in the fundamental tension experienced between the high R&D spend necessitated by the cost of pharmaceutical innovation and declining returns on this expenditure in terms generating new product sales and FDA approval rates, which have remained broadly constant at an average of 20–35 approvals per year. The new R&D outsourcing strategy has not delivered an increase in marketable drug discoveries or new ‘blockbuster’ profits. Instead, shareholder returns have been maintained through Big Pharma's decision to distribute cash back to shareholders via share buybacks and dividends (as advocated by Jensen). Thus we conclude that such developments within Big Pharma worldwide are best explained through the lens of a financialisation, as opposed to a resource-based or transaction cost framework.

JournalCritical Perspectives on Accounting
Journal citation25 (1), pp. 67-77
ISSN1045-2354
Year2014
PublisherElsevier
Digital Object Identifier (DOI)doi:10.1016/j.cpa.2012.10.003
Publication dates
Published16 Dec 2012

Related outputs

Stakeholder interactions and corporate social responsibility (CSR) practices: Evidence from the Zambian copper mining sector
Phiri, O., Mantzari, E. and Gleadle, P. 2018. Stakeholder interactions and corporate social responsibility (CSR) practices: Evidence from the Zambian copper mining sector. Accounting, Auditing & Accountability Journal. 32 (1), pp. 26-54. doi:10.1108/AAAJ-04-2016-2540

The role of institutional context in the development of the SME biotech sector in Poland
Gleadle, P., Micek, G. and Dawidko, P. 2014. The role of institutional context in the development of the SME biotech sector in Poland. Studies of the Industrial Geography Commission. (25), pp. 132-150.

Critical accounts and perspectives on financialization
Gleadle, P., Haslam, C. and Yin, Y.P. 2014. Critical accounts and perspectives on financialization. Critical Perspectives on Accounting. 25 (1), pp. 1-4. doi:10.1016/j.cpa.2012.11.010

'The ground beneath my feet': projects, project management and the intensified control of R&D engineers
Gleadle, P., Hodgson, D. and Storey, J. 2012. 'The ground beneath my feet': projects, project management and the intensified control of R&D engineers. New Technology, Work and Employment. 27 (3), pp. 163-177.

UK bio-pharma: innovation, re-invention and capital at risk
Gleadle, P., Haslam, C. and Tsitsianis, N. 2011. UK bio-pharma: innovation, re-invention and capital at risk. Scotland The Institute of Chartered Accountants of Scotland (ICAS).

Book review: 'Interpreting Interviews' by Mats Alvesson
Gleadle, P. 2011. Book review: 'Interpreting Interviews' by Mats Alvesson. Management Learning. 42 (3), pp. 349-352. doi:10.1177/1350507611410138

An exploratory study of an early stage R&D-intensive firm under financialization
Gleadle, P. and Haslam, C. 2010. An exploratory study of an early stage R&D-intensive firm under financialization. Accounting Forum. 34 (1), pp. 54-65.

Bio-pharma: a financialized business model
Gleadle, P., Andersson, T., Haslam, C. and Tsitsianis, N. 2010. Bio-pharma: a financialized business model. Critical Perspectives on Accounting. 21 (7), pp. 631-641.

Culture as a dynamic capability: the case of 3M in the United Kingdom
Gleadle, P. and Bowman, C. 2009. Culture as a dynamic capability: the case of 3M in the United Kingdom. in: Jemielniak, D. and Kociatkiewicz, J. (ed.) Handbook of research on knowledge-intensive organizations USA Idea Group. pp. 330–347

Afterword: segmentation, reorientation and new exclusions
Gleadle, P., Cornelius, N. and Pezet, E. 2008. Afterword: segmentation, reorientation and new exclusions. Organization. 15 (3), pp. 463-465. doi:10.1177/1350508408088545

Old and new timings in a high-tech firm
Gleadle, P. 2008. Old and new timings in a high-tech firm. in: Jemielniak, D. and Kociatkiewicz, J. (ed.) Management practices in high-tech environments USA IGI Global. pp. 133–151

Enterprising selves: how governmentality meets agency
Gleadle, P., Cornelius, N. and Pezet, E. 2008. Enterprising selves: how governmentality meets agency. Organization. 15 (3), pp. 307-313. doi:10.1177/1350508408088529

A case study of financialization and EVA©
Gleadle, P. and Cornelius, N. 2008. A case study of financialization and EVA©. Critical Perspectives on Accounting. 19 (8), p. 1219–1238.

La conduite de soi et les sujets entreprenants: les cas Midco et Labco
Gleadle, P. and Cornelius, N. 2007. La conduite de soi et les sujets entreprenants: les cas Midco et Labco. in: Pezet, E. (ed.) Management et conduite de soi: enquête sur les ascèses de la performance Paris, France Vuibert. pp. 129-152

Change and continuity in writing about change and continuity
Gleadle, P., Cornelius, N., Pezet, E. and Salaman, G. 2007. Change and continuity in writing about change and continuity. Journal of Organizational Change Management. 20 (4), pp. 473-477. doi:10.1108/jocm.2007.02320daa.001

Managing change across boundaries: boundary-shaking practices
Gleadle, P., Balogun, J., Hailey, V., Willmott, H. and Veronica Hope Hailey 2005. Managing change across boundaries: boundary-shaking practices. British Journal of Management. 16 (4), p. 261–278. doi:10.1111/j.1467-8551.2005.00463.x

Organising for change: conflicts and dilemmas in surveying and consulting
Gleadle, P. and Tranfield, D. 2003. Organising for change: conflicts and dilemmas in surveying and consulting. Cranfield Advanced Management Research Centre, Cranfield School of Management.

Permalink - https://westminsterresearch.westminster.ac.uk/item/990x1/restructuring-and-innovation-in-pharmaceuticals-and-biotechs-the-impact-of-financialisation


Share this
Tweet
Email

Usage statistics

35 total views
0 total downloads
0 views this month
0 downloads this month
These values are for the period from September 2nd 2018, when this repository was created

Export as